{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T09:33:34Z","timestamp":1786527214953,"version":"build-2736575974"},"reference-count":30,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA230352"],"award-info":[{"award-number":["R01CA230352"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["1R01HS019356"],"award-info":[{"award-number":["1R01HS019356"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["1R01HS022640"],"award-info":[{"award-number":["1R01HS022640"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["CE\u201012\u201011\u20104667"],"award-info":[{"award-number":["CE\u201012\u201011\u20104667"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000011"],"award-info":[{"award-number":["UL1TR000011"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"abstract":"\n Objectives<\/jats:title>\n To report long\u2010term oncological outcomes for men with clinically localised prostate cancer (PCa) treated with contemporary modalities in a population\u2010based United States cohort.<\/jats:p>\n <\/jats:sec>\n \n Patients and Methods<\/jats:title>\n The Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) study prospectively enrolled men with clinically localised PCa from 2011 to 2012. Patients were stratified into two groups: favourable prognosis (clinical T stage [cT]1\u2013T2a\/bN0M0, prostate\u2010specific antigen [PSA] level \u2264\u200920\u2009ng\/mL, Grade Group 1\u20132) and unfavourable prognosis (cT2cN0M0, PSA level 20\u201350\u2009ng\/mL, or Grade Group 3\u20135). Main outcomes were PCa\u2010specific mortality (PCSM), composite progression to advanced disease (metastasis, PCSM event, or systemic therapy), and overall survival (OS). Cox regression models adjusted for demographic and clinical covariates.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of the 2604 men included, 73% were White, 15% Black, and 7% Hispanic. All hazard ratios (HRs) were adjusted for demographic and clinical covariates using multivariable Cox and Fine\u2010Gray models. In the favourable group, compared with surgery, external beam radiotherapy (EBRT; HR 1.5, 95% confidence interval [CI] 1.1\u20132.1,\n P<\/jats:italic>\n \u2009<\u20090.01), brachytherapy (HR 2.1, 95% CI 1.3\u20133.3,\n P<\/jats:italic>\n \u2009<\u20090.01), and active surveillance (HR 1.5, 95% CI 1.1\u20132.1,\n P<\/jats:italic>\n \u2009=\u20090.02) were associated with higher all\u2010cause mortality; the 10\u2010year cumulative incidence of PCSM was \u22641.5% for all five strategies, and progression did not differ. In the unfavourable group, EBRT was associated with worse OS (HR 2.8, 95% CI 1.9\u20134.3,\n P<\/jats:italic>\n \u2009<\u20090.01), with no adjusted differences in PCSM (10\u2010year cumulative incidence 3.5% after surgery vs 8.8% after EBRT) or progression across treatments.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n In this population\u2010based cohort treated with contemporary modalities, the 10\u2010year risk of PCa death was low across all treatment strategies, including active surveillance. OS differences favouring surgery likely reflect residual confounding from baseline health and treatment selection. These findings underscore the importance of patient values and comorbidities in shared decision\u2010making for localised PCa.<\/jats:p>\n <\/jats:sec>","DOI":"10.1111\/bju.70410","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T08:55:50Z","timestamp":1786524950000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long\u2010term oncological outcomes from a prospective cohort of patients with localised prostate cancer"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1016-2025","authenticated-orcid":false,"given":"Avi S.","family":"Baskin","sequence":"first","affiliation":[{"name":"Department of Urology University of California Irvine Irvine CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E.","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology The University of Texas MD Anderson Cancer Center Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2580-2697","authenticated-orcid":false,"given":"David F.","family":"Penson","sequence":"additional","affiliation":[{"name":"Department of Urology Vanderbilt University Medical Center Nashville TN USA"},{"name":"Veterans Affairs Tennessee Valley Geriatric Research Education and Clinical Center Nashville TN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5959-7097","authenticated-orcid":false,"given":"Li\u2010Ching","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics Vanderbilt University Medical Center Nashville TN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9033-7410","authenticated-orcid":false,"given":"Zhiguo","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Biostatistics Vanderbilt University Medical Center Nashville TN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8552-4951","authenticated-orcid":false,"given":"Bashir Al Hussein Al","family":"Awamlh","sequence":"additional","affiliation":[{"name":"Weill Cornell Medicine and NewYork\u2010Presbyterian Hospital New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4365-8622","authenticated-orcid":false,"given":"Daniel D.","family":"Joyce","sequence":"additional","affiliation":[{"name":"Department of Urology Vanderbilt University Medical Center Nashville TN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia K.","family":"Morgans","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology Dana\u2010Farber Cancer Institute Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Tosoian","sequence":"additional","affiliation":[{"name":"Department of Urology Vanderbilt University Medical Center Nashville TN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5990-4026","authenticated-orcid":false,"given":"Christopher J.D.","family":"Wallis","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Urology Mount Sinai Hospital New York NY USA"},{"name":"Division of Urology, Department of Urology University of Toronto Toronto Ontario Canada"},{"name":"Division of Urology, Department of Surgical Oncology University Health Network Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6956-6879","authenticated-orcid":false,"given":"Michael","family":"Goodman","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Emory University Rollins School of Public Health Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5898-2308","authenticated-orcid":false,"given":"Ann S.","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Department of Population and Public Health Sciences Keck School of Medicine at the University of Southern California Los Angeles CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao\u2010Cheng","family":"Wu","sequence":"additional","affiliation":[{"name":"Epidemiology and Population Health Program Louisiana State University Health New Orleans School of Public Health New Orleans LA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa E.","family":"Paddock","sequence":"additional","affiliation":[{"name":"Cancer Epidemiology Services New Jersey Department of Health Trenton NJ USA"},{"name":"Rutgers Cancer Institute of New Jersey New Brunswick NJ USA"},{"name":"Rutgers School of Public Health Piscataway NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3341-4018","authenticated-orcid":false,"given":"Antoinette","family":"Stroup","sequence":"additional","affiliation":[{"name":"Cancer Epidemiology Services New Jersey Department of Health Trenton NJ USA"},{"name":"Rutgers Cancer Institute of New Jersey New Brunswick NJ USA"},{"name":"Rutgers School of Public Health Piscataway NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brock B.","family":"O'Neil","sequence":"additional","affiliation":[{"name":"Department of Urology University of Utah Health Salt Lake City UT USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8908-9165","authenticated-orcid":false,"given":"Tatsuki","family":"Koyama","sequence":"additional","affiliation":[{"name":"Department of Biostatistics Vanderbilt University Medical Center Nashville TN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Barocas","sequence":"additional","affiliation":[{"name":"Department of Urology Vanderbilt University Medical Center Nashville TN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.6004\/jnccn.2024.0019","article-title":"NCCN guidelines\u00ae insights: prostate cancer, version 3.2024","volume":"22","author":"Schaeffer EM","year":"2024","journal-title":"J Natl Compr Cancer Netw"},{"key":"e_1_2_10_3_1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/JU.0000000000002759","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline. Part III: principles of radiation and future directions","volume":"208","author":"Eastham JA","year":"2022","journal-title":"J Urol"},{"key":"e_1_2_10_4_1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/jama.2023.26491","article-title":"Functional outcomes after localized prostate cancer treatment","volume":"331","author":"Al Hussein Al Awamlh B","year":"2024","journal-title":"JAMA"},{"key":"e_1_2_10_5_1","doi-asserted-by":"crossref","first-page":"104.e1","DOI":"10.1016\/j.urolonc.2022.07.014","article-title":"Functional outcomes after prostate cancer treatment: a comparison between single and multiple modalities","volume":"41","author":"Muise A","year":"2023","journal-title":"Urol Oncol"},{"key":"e_1_2_10_6_1","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJMoa1209978","article-title":"Long\u2010term functional outcomes after treatment for localized prostate cancer","volume":"31","author":"Resnick MJ","year":"2013","journal-title":"N Engl J Med"},{"key":"e_1_2_10_7_1","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","article-title":"Fifteen\u2010year outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"388","author":"Hamdy FC","year":"2023","journal-title":"N Engl J Med"},{"key":"e_1_2_10_8_1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa1615869","article-title":"Follow\u2010up of prostatectomy versus observation for early prostate cancer","volume":"377","author":"Wilt TJ","year":"2017","journal-title":"N Engl J Med"},{"key":"e_1_2_10_9_1","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1311593","article-title":"Radical prostatectomy or watchful waiting in early prostate cancer","volume":"370","author":"Bill\u2010Axelson A","year":"2024","journal-title":"N Engl J Med"},{"key":"e_1_2_10_10_1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2217\/cer.13.34","article-title":"Using a population\u2010based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study","volume":"2","author":"Barocas DA","year":"2013","journal-title":"J Comp Eff Res"},{"key":"e_1_2_10_11_1","unstructured":"National Comprehensive Cancer Network.Prostate Cancer (version 1.2025).2024"},{"key":"e_1_2_10_12_1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0277-9536(91)90150-B","article-title":"The MOS social support survey","volume":"32","author":"Sherbourne CD","year":"1991","journal-title":"Soc Sci Med"},{"key":"e_1_2_10_13_1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0749-3797(18)30622-6","article-title":"Screening for depression in well older adults: evaluation of a short form of the CES\u2010D (Center for Epidemiologic Studies Depression Scale)","volume":"10","author":"Andresen EM","year":"1994","journal-title":"Am J Prev Med"},{"key":"e_1_2_10_14_1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.7326\/0003-4819-124-5-199603010-00007","article-title":"Characteristics of physicians with participatory decision\u2010making styles","volume":"124","author":"Kaplan SH","year":"1996","journal-title":"Ann Intern Med"},{"key":"e_1_2_10_15_1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00005650-199303000-00006","article-title":"The MOS 36\u2010item short\u2010form health survey (SF\u201036): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs","volume":"31","author":"McHorney CA","year":"1993","journal-title":"Med Care"},{"key":"e_1_2_10_16_1","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/cncr.22615","article-title":"Assessment of prognosis with the total illness burden index for prostate cancer: aiding clinicians in treatment choice","volume":"1","author":"Litwin MS","year":"2007","journal-title":"Cancer"},{"key":"e_1_2_10_17_1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.eururo.2014.09.017","article-title":"Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer\u2010specific mortality by nomogram\u2010predicted risks of biochemical recurrence","volume":"67","author":"Lee BH","year":"2015","journal-title":"Eur Urol"},{"key":"e_1_2_10_18_1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E\u2010value","volume":"15","author":"VanderWeele TJ","year":"2017","journal-title":"Ann Intern Med"},{"key":"e_1_2_10_19_1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.eururo.2023.09.024","article-title":"Long\u2010term prostate cancer\u2010specific mortality after prostatectomy, brachytherapy, external beam radiation therapy, hormonal therapy, or monitoring for localized prostate cancer","volume":"85","author":"Herlemann A","year":"2024","journal-title":"Eur Urol"},{"key":"e_1_2_10_20_1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/21681805.2018.1520295","article-title":"SPCG\u201015: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer","volume":"52","author":"Stranne J","year":"2018","journal-title":"Scand J Urol"},{"key":"e_1_2_10_21_1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.eururo.2015.11.010","article-title":"Surgery versus radiotherapy for clinically\u2010localized prostate cancer: a systematic review and meta\u2010analysis","volume":"70","author":"Wallis CJD","year":"2016","journal-title":"Eur Urol"},{"key":"e_1_2_10_22_1","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1002\/cncr.23452","article-title":"Limits of observational data in determining outcomes from cancer therapy","volume":"112","author":"Giordano SH","year":"2008","journal-title":"Cancer"},{"key":"e_1_2_10_23_1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/JU.0000000000002757","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline, part I: Introduction, risk assessment, staging, and risk\u2010based management","volume":"208","author":"Eastham JA","year":"2022","journal-title":"J Urol"},{"key":"e_1_2_10_24_1","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1001\/jama.2024.6695","article-title":"Long\u2010term outcomes in patients using protocol\u2010directed active surveillance for prostate cancer","volume":"331","author":"Newcomb LF","year":"2024","journal-title":"JAMA"},{"key":"e_1_2_10_25_1","first-page":"3","article-title":"Review of principles of salvage radical prostatectomy","volume":"6","author":"May DN","year":"2020","journal-title":"AME Med J"},{"key":"e_1_2_10_26_1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00345-012-0928-8","article-title":"Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: a multi\u2010center experience and literature review","volume":"31","author":"Peters M","year":"2013","journal-title":"World J Urol"},{"key":"e_1_2_10_27_1","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.clon.2021.10.012","article-title":"Comparative effectiveness analyses of salvage prostatectomy and salvage radiotherapy outcomes following focal or whole\u2010gland ablative therapy (high\u2010intensity focused ultrasound, cryotherapy or electroporation) for localised prostate cancer","volume":"34","author":"Nathan A","year":"2022","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"e_1_2_10_28_1","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.eururo.2020.11.010","article-title":"A systematic review and meta\u2010analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER)","volume":"80","author":"Valle LF","year":"2021","journal-title":"Eur Urol"},{"key":"e_1_2_10_29_1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.prnil.2024.09.003","article-title":"Oncological outcomes after radical prostatectomy of localized prostate cancer: stratified by magnetic resonance imaging and risk classification","volume":"12","author":"Jung G","year":"2024","journal-title":"Prostate Int"},{"key":"e_1_2_10_30_1","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.ijrobp.2021.07.133","article-title":"Validation of a 22\u2010gene genomic classifier in the NRG oncology\/RTOG 9202, 9413 and 9902 phase III randomized trials: a biopsy\u2010based individual patient meta\u2010analysis in high\u2010risk prostate cancer","volume":"111","author":"Nguyen PL","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"e_1_2_10_31_1","doi-asserted-by":"crossref","first-page":"e504","DOI":"10.1016\/j.ijrobp.2025.06.2653","article-title":"Evaluating the correlation between genomic classifier and digital pathology\u2010based multi\u2010modal AI biomarkers in localized prostate cancer","volume":"123","author":"Olabumuyi A","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bju.70410","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bju.70410","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bju.70410","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T08:55:57Z","timestamp":1786524957000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/bju.70410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":30,"alternative-id":["10.1111\/bju.70410"],"URL":"https:\/\/doi.org\/10.1111\/bju.70410","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"2026-08-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"bju.70410"}}